Alzheimer's Disease Trial, Not Yet Recruiting NCT07669272 Sponsor: Southwest Hospital, China Condition: Alzheimer's Disease
Back to Alzheimers Disease

Alzheimer's Disease Trial, Not Yet Recruiting

NCT07669272
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who have been diagnosed with probable Alzheimer's disease based on recognised 2011 and 2018 medical diagnostic guidelines, including specific biological markers that confirm the condition.
  • People aged 50 to 80 years old at the time of signing the consent forms.
  • People with severe memory and thinking problems, shown by a score below 10 on a standard cognitive test called the Mini-Mental State Examination (MMSE).
  • People whose memory and thinking abilities have been getting progressively worse for more than 6 months, as reported by themselves or a carer.
  • People who have not shown any improvement after more than 6 months of standard medication treatment for Alzheimer's disease.
  • People who have a designated companion who is willing to sign consent forms, spends at least 10 hours per week in contact with the patient, and can attend study visits with them.
  • People who are able to complete assessments and examinations, either on their own or with help from their companion.
  • People who are willing to follow all study procedures, examinations, and any surgical treatment involved in the trial.
  • People whose patient or legal representative is able to sign written consent forms and agrees to follow all trial requirements.
  • People and their families who have been informed about the study's purpose, expected outcomes, and possible risks, and who voluntarily agree to provide biological samples and take part.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have a serious brain or nervous system condition, other than Alzheimer's disease, that affects thinking ability or their ability to participate in the study.
  • People who have a serious or unstable illness affecting the heart, liver, kidneys, lungs, hormones, blood, or mental health, or whose life expectancy is less than 24 months.
  • People who have medical conditions that make surgery unsafe, including serious blood clotting disorders, a heart attack or respiratory failure in the past 30 days, significant liver damage, or severely reduced kidney function (confirm with trial site for specific test values).
  • People who have a serious primary mental health condition, other than Alzheimer's disease, that would interfere with cognitive testing or evaluating the treatment's effects.
  • People who have had bleeding in the brain or a serious head injury within the past year.
  • People who have had problems with alcohol or drug misuse or dependence within the past year.
  • People who have a known allergy to any of the following substances used in the study: indocyanine green, gadolinium contrast agent, or the imaging agents 18F-florbetapir or 18F-flortaucipir.
  • People who are unable to undergo PET scan imaging for any reason.
  • People who the trial investigators consider unsuitable for the study for any other reason.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

If this is close to home

This page includes language about advanced illness, prognosis, or palliative care, because that is how the trial's eligibility criteria are written. Seeing it set out plainly can land hard, whether it is about you or about someone you are caring for. You do not have to be at a crisis point to talk to someone.

  • Griefline — grief and loss counselling, 9am to 6pm weekdays and midday to 6pm weekends (AEST/AEDT): 1300 845 745
  • Carer Gateway — practical and emotional support if you are caring for someone, 8am to 5pm weekdays: 1800 422 737
  • Canteen — for 12 to 25 year olds affected by cancer, their own or a family member's: 1800 945 215
  • Palliative Care Australia — directory of palliative care services near you: palliativecare.org.au
  • Lifeline — 24/7, for any kind of distress, at any hour the services above are closed: 13 11 14

Palliative care is not the same as giving up on treatment, and it is not only for the last weeks of life. It is symptom and comfort care that can run alongside active treatment, including a clinical trial.

Outside Australia? The numbers above are Australian and will not work from overseas. Find a Helpline is a free directory of support and crisis lines in over 130 countries, run by ThroughLine with the International Association for Suicide Prevention.

Voxsanity is not a counselling or medical service, and nothing on this page is medical advice. More Australian services are listed on our support lines page.

Contact this trial

Phone: +8602368765911

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
Southwest Hospital, China
Registry
ClinicalTrials.gov
Start date
1 October 2026
Est. completion
30 September 2028

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Sum of Boxes (CDR-SB) Total Score

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov